Podiatrists in Astoria, OR Accepting Medicare

6 Podiatrists found. Showing 1 - 6

Michael A. Murdock, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4075    Fax: 503-338-4076

Mark Owen Ellis, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 582 22nd Street, Astoria, OR 97103 Phone: 503-325-0045    Fax: 503-325-3242

Mark Rawson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4075    Fax: 503-338-4076

Rivershore Foot And Ankle Clinic Inc. Podiatrist Medicare: Medicare Enrolled Practice Location: 2120 Exchange St Ste 110, Astoria, OR 97103 Phone: 503-325-5655    Fax: 503-325-1317

Dr. Nancy Ray, MD Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2120 Exchange St Ste 110, Astoria, OR 97103 Phone: 503-325-5655

Rivershore Foot & Ankle Clinic, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2120 Exchange St Ste 110, Astoria, OR 97103 Phone: 503-325-5655

News Archive

Stage and grade dominate RCC outcomes

Tumor grade and American Joint Committee on Cancer stage have emerged as the most important predictors of mortality in a competing risks analysis of patients undergoing nephrectomy for renal cell carcinoma.

Single gene defines difference between aggressive and non-aggressive forms of thymoma

For a rare form of cancer called thymoma, researchers have discovered a single gene defining the difference between a fast-growing tumor requiring aggressive treatment and a slow-growing tumor that doesn't require extensive therapy.

SCN study outlines impacts of targeted skills training on Canada's regenerative medicine sector

Today, Canada's Stem Cell Network (SCN) released a study entitled, Training Tomorrow's Research Leaders, outlining the impacts of nearly 20 years of targeted skills training on Canada's emergent regenerative medicine sector.

Diet may regulate obesity health risks, but genes decide, says new research

The risk of obese people developing the metabolic syndrome that leads to diabetes, hypertension, and heart disease, can not be solved by a one-size-fits-all diet programme, according to new scientific findings.

Phase I study of SNS-032 demonstrates safety, potential clinical activity in treating B-cell malignancies

A Phase I clinical trial of SNS-032, one of the first in a new class of drugs that inhibit cyclin-dependent kinases, demonstrated the drug's safety and potential clinical action against advanced chronic lymphocytic leukemia. Cyclin-dependent kinases are enzymatic proteins that are integrally involved in cellular metabolism, renewal and signaling, and are thought to play key roles in the growth of cancers.

Read more Medical News

› Verified 4 days ago